$2935 | SAVE $400 | Single User
$3238 | SAVE $442 | Site License
$4858 | SAVE $662 | Enterprise License

Asia-Pacific Infectious Disease Therapeutics Market by Mode of Treatment- (Drugs, Vaccines), by target organism – (Antibacterial, Antifungal, Antiviral, Antiparasitic, others) by infection type – (Bacterial, Viral, fungal, Parasitic, others), by distribution channels (Hospitals, Clinics and others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
[Report Updated: 01-11-2016]

Published by Market Data Forecast: 01 Nov 2016 | 49364 | In Stock
Related Topics: AstraZeneca , GlaxoSmithKline , Infectious Disease , Novartis , Pfizer , Roche , Vaccine

Introduction

The Asia-Pacific Infectious Disease Therapeutics Market was worth .436 Billion in 2016 and estimated to reach .045 Billion by the end of 2021 with a growing potential of 4.97 %. APAC is expected to account the second largest share in the market due to increasing pool of patients, and government funding.

Various microorganisms like bacteria, fungi, viruses and parasites and others causes infectious diseases such as HIV, malaria, tuberculosis, influenza. Various infectious diseases are mostly caused by poor sanitation and inadequate personal hygiene. These diseases are transmitted either through direct or indirect contact. Anti-infective drugs are used to inhibit or destroy the growth of disease causing agents. Antibacterial, antifungal, antiparasitic, antiviral drugs are some of the anti- infective drugs used for the treatment of these diseases.

Asia-Pacific market is mainly driven by growing incidence of infectious diseases, rising health care expenditure and growing geriatric population, growing healthcare awareness, increasing government funding’s in developing countries. Generic erosion, Patent expiration of infectious disease drugs are the factors that are hampering the growth of the market.

The Asia-Pacific Infectious disease therapeutics market is categorized based on Mode of treatment into Drugs and Vaccines. Based on infection type the market is categorized into Bacterial, viral, fungal, parasite and others. Based on distribution channels the market is categorized into hospitals, pharmacies and others. Based on Geography, the Asia-Pacific Infectious disease therapeutics market is analyzed under various regions namely China, India, Japan, south korea and Australia.

Some of the major companies operating in Asia-Pacific Infectious disease Therapeutics Market F. Hoffmann-La Roche, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Novartis, AbbVie, , AstraZeneca, Bayer, Bristol-Myers Squibb and Sanofi.

Table of Contents
for Asia-Pacific Infectious Disease Therapeutics Market by Mode of Treatment- (Drugs, Vaccines), by target organism – (Antibacterial, Antifungal, Antiviral, Antiparasitic, others) by infection type – (Bacterial, Viral, fungal, Parasitic, others), by distribution channels (Hospitals, Clinics and others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) [Report Updated: 01-11-2016]

  • 1. INTRODUCTION 1.1 MARKET DEFINITION 1

    1.2 KEY DELIVERABLES OF THE STUDY 2

    1.3 BASE CURRENCY, BASE YEAR, AND FORECAST PERIOD 2

    1.4 GENERAL STUDY ASSUMPTIONS 3

    2. RESEARCH APPROACH AND METHODOLOGY 4

    2.1 INTRODUCTION 4

    2.1.1 Size Estimation 4

    2.1.2 Forecasting Methodology 4

    2.2 RESEARCH PHASES 5

    2.2.1 Secondary Research 5

    2.2.2 Primary Research 5

    2.2.3 Econometric Modelling 6

    2.2.4 Expert Validation 6

    2.3 ANALYSIS DESIGN 7

    2.4 STUDY TIMELINE 8

    3. OVERVIEW 9

    3.1 EXECUTIVE SUMMARY 9

    3.2 KEY INFERENCES 11

    4. MARKET DYNAMICS 14

    4.1 MARKET DRIVERS 14

    4.1.1 Rising Prevalence of Diseases 14

    4.1.2 Increasing Investments by Companies 15

    4.1.3 Technological Advancements 16

    4.1.4 Favorable Government Funding 16

    4.2 MARKET RESTRAINTS 17

    4.2.1 Huge Capital Expenditures 17

    4.2.2 Stringent Regulatory Framework 17

    4.3 MARKET OPPORTUNITIES 18

    4.3.1 Government Initiatives 18

    4.3.2 Technlogical Advancements 18

    4.4 MARKET CHALLENGES 19

    4.4.1 Drug Resistence 19

    4.4.2 Alternative Treatments 20

    5. MARKET SEGMENTATION 21

    5.1 INTRODUCTION 21

    5.1.1 Apac Infectious Disease Therapeutics Market, By Type 22

    5.1.2 Apac Infectious Disease Therapeutics Market, By Infection 24

    5.1.3 Apac Infectious Disease Therapeutics Market, By End User 26

    6. GEOGRAPHICAL ANALYSIS 28

    6.1 INTRODUCTION 28

    6.2 CHINA 30

    6.2.1 China Infectious Disease Therapeutics Market, By Type 30

    6.2.2 China Infectious Disease Therapeutics Market, By Infection 31

    6.2.3 China Infectious Disease Therapeutics Market, By End User 32

    6.3 INDIA 33

    6.3.1 India Infectious Disease Therapeutics Market, By Type 33

    6.3.2 India Infectious Disease Therapeutics Market, By Infection 34

    6.3.3 India Infectious Disease Therapeutics Market, By End User 35

    6.4 JAPAN 36

    6.4.1 Japan Infectious Disease Therapeutics Market, By Type 36

    6.4.2 Japan Infectious Disease Therapeutics Market, By Infection 37

    6.4.3 Japan Infectious Disease Therapeutics Market, By End User 38

    6.5 AUSTRALIA 39

    6.5.1 Australia Infectious Disease Therapeutics Market, By Type 39

    6.5.2 Australia Infectious Disease Therapeutics Market, By Infection 40

    6.5.3 Australia Infectious Disease Therapeutics Market, By End User 41

    6.6 SOUTH KOREA 42

    6.6.1 South Korea Infectious Disease Therapeutics Market, By Type 42

    6.6.2 South Korea Infectious Disease Therapeutics Market, By Infection 43

    6.6.3 South Korea Infectious Disease Therapeutics Market, By End User 44

    7. STRATEGIC ANALYSES 45

    7.1 PESTLE ANALYSIS 45

    7.1.1 Political 46

    7.1.2 Economical 48

    7.1.3 Social 49

    7.1.4 Technological 50

    7.1.5 Legal 53

    7.1.6 Environmental 55

    7.2 PORTER’S FIVE FORCES ANALYSIS 57

    7.2.1 Threat of New Entrants 57

    7.2.2 Threat of Substitution 58

    7.2.3 Bargaining Power of Buyers 59

    7.2.4 Bargaining Power of Suppliers 60

    7.2.5 Competitive Rivarly 61

    8. MARKET LEADER’S ANALYSIS 62

    8.1 ABBVIE 62

    8.1.1 Overview 62

    8.1.2 Products 62

    8.1.3 Financials (in USD Million) 63

    8.1.4 Recent Developments 63

    8.1.5 SWOT Analysis 64

    8.1.6 Analyst outlook 65

    8.2 ASTRAZENECA PLC. 66

    8.2.1 Overview 66

    8.2.2 Products 66

    8.2.3 Financials (USD Millions) 67

    8.2.4 Recent Developments 67

    8.2.5 SWOT Analysis 68

    8.2.6 Analyst View 68

    8.3 BAYER AG 69

    8.3.1 Overview 69

    8.3.2 Products 69

    8.3.3 Financials (USD Millions) 70

    8.3.4 Analyst View 70

    8.4 BRISTOL-MYERS SQUIBB 71

    8.4.1 Overview 71

    8.4.2 Products 71

    8.4.3 Financials (in USD Million) 71

    8.4.4 RECENT DEVELOPMENTS 72

    8.4.5 Analyst outlook 72

    8.5 GLAXOSMITHKLINE PLC 73

    8.5.1 Overview 73

    8.5.2 Products 73

    8.5.3 Financials (USD Millions) 74

    8.5.4 Recent Developments 74

    8.5.5 Analyst view 75

    8.6 JOHNSON AND JOHNSON 76

    8.6.1 Overview 76

    8.6.2 Products 76

    8.6.3 Financials (USD Millions) 77

    8.6.4 Recent Developments 77

    8.6.5 Analyst View 78

    8.7 MERCK & CO. 79

    8.7.1 Overview 79

    8.7.2 Products 79

    8.7.3 Financials (in USD Million) 81

    8.7.4 Recent Developments 81

    8.7.5 SWOT Analysis 82

    8.7.6 Analyst View 82

    8.8 NOVARTIS INTERNATIONAL AG 84

    8.8.1 Overview 84

    8.8.2 Products 84

    8.8.3 Recent Developments 85

    8.8.4 Analyst Overview 85

    8.9 PFIZER, INC 86

    8.9.1 Overview 86

    8.9.2 Financials (in USD Million) 86

    8.9.3 Products 87

    8.9.4 Recent Developments 88

    8.9.5 SWOT Analysis 89

    8.9.6 Analyst Overview 89

    8.10 ROCHE HOLDING AG 90

    8.10.1 Overview 90

    8.10.2 Products 90

    8.10.3 Financials (in USD Million) 91

    8.10.4 Recent development 91

    8.10.5 SWOT Analysis 92

    8.10.6 Analyst View 93

    8.11 SANOFI 94

    8.11.1 Overview 94

    8.11.2 Products 94

    8.11.3 Recent Developments 95

    8.11.4 Analyst Overview 95

    9. COMPETITIVE LANDSCAPE 96

    9.1 COMPARATIVE ANALYSIS 96

    9.1.1 Market Share Analysis 96

    9.1.2 Competitive Scenario 97

    9.2 MERGERS & ACQUISITIONS 98

    9.3 COLLABORATIONS, AGREEMENTS & EXPANSIONS 100

    9.4 NEW PRODUCT LAUNCHES 101

    10. MARKET OUTLOOK 102

Additional Details

Publisher

Market Data Forecast

Publisher Information

Market Data Forecast [MDF] is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research. 

Reference

49364 | Asia-Pacific Infectious Disease Therapeutics Market

Number of Pages

111

Report Format

PDF

Market Data Forecast Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 12% today! A. Menarini Asia-Pacific Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryA. Menarini Asia-Pacific Holdings Pte. Ltd. (A. Menarini Asia-Pacific), formerly Invida Group...
29 Jul 2016 by Global Data USD $220 (normally
USD $250)
More Info
SAVE 12% today! Zuellig Pharma Asia Pacific Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryZuellig Pharma Asia Pacific Ltd. (Zuellig Pharma) is a healthcare service provider that provi...
13 May 2016 by Global Data USD $220 (normally
USD $250)
More Info
SAVE 12% today! A. Menarini Asia-Pacific Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryA. Menarini Asia-Pacific Holdings Pte. Ltd. (A. Menarini Asia-Pacific), formerly Invida Group...
05 May 2016 by Global Data USD $220 (normally
USD $250)
More Info
SAVE 12% today! Zuellig Pharma Asia Pacific Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryZuellig Pharma Asia Pacific Ltd. (Zuellig Pharma) is a healthcare service provider that provi...
17 Mar 2016 by Global Data USD $220 (normally
USD $250)
More Info
SAVE 12% today! A. Menarini Asia-Pacific Holdings Pte. Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryA. Menarini Asia-Pacific Holdings Pte. Ltd. (A. Menarini Asia-Pacific), formerly Invida Group...
08 Mar 2016 by Global Data USD $220 (normally
USD $250)
More Info
SAVE 12% today! Asia-Pacific Hip Replacement Procedures Outlook to 2021
Asia-Pacific Hip Replacement Procedures Outlook to 2021SummaryGlobalData’s new report, "Asia-Pacific...
05 Oct 2015 by Global Data USD $1,320 (normally
USD $1,500)
More Info
SAVE 12% today! Asia-Pacific Knee Replacement Procedures Outlook to 2021
Asia-Pacific Knee Replacement Procedures Outlook to 2021SummaryGlobalData’s new report, "Asia-Pacifi...
05 Oct 2015 by Global Data USD $1,320 (normally
USD $1,500)
More Info
SAVE 12% today! Asia-Pacific Shoulder Replacement Procedures Outlook to 2021
Asia-Pacific Shoulder Replacement Procedures Outlook to 2021SummaryGlobalData’s new report, "Asia-Pa...
01 Oct 2015 by Global Data USD $1,320 (normally
USD $1,500)
More Info
SAVE 12% today! Asia-Pacific Small Joints Procedures Outlook to 2021
Asia-Pacific Small Joints Procedures Outlook to 2021SummaryGlobalData’s new report, "Asia-Pacific Sm...
01 Oct 2015 by Global Data USD $1,320 (normally
USD $1,500)
More Info
SAVE 12% today! Branded Generics in South East Asia: Current and Future Opportunities
IntroductionWith its fast-growing, young population and projected pharmaceutical sales in excess of ...
01 Apr 2012 by FirstWord Pharma USD $832 (normally
USD $945)
More Info

This report is published by Market Data Forecast

Market Data Forecast [MDF] is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research. 

Download Free Report Summary PDF

Asia-Pacific Infectious Disease Therapeutics Market by Mode of Treatment- (Drugs, Vaccines), by target organism – (Antibacterial, Antifungal, Antiviral, Antiparasitic, others) by infection type – (Bacterial, Viral, fungal, Parasitic, others), by distribution channels (Hospitals, Clinics and others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) [Report Updated: 01-11-2016] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...